Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vision, Subnormal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05048550
What this trial is testing

Babies in Glasses; a Feasibility Study.

Who this might be right for
Cerebral Visual ImpairmentRefractive and Accommodative DisordersHypoxic-Ischemic Encephalopathy+1 more
Great Ormond Street Hospital for Children NHS Foundation Trust 55
Not applicableStudy completedNCT04524910
What this trial is testing

Learn More About How Drug Aflibercept Works in Canadian Patients With Reduced Vision Caused by New Blood Vessels Growing in the Eye (Myopic Choroidal Neovascularization or mCNV)

Who this might be right for
Myopic Choroidal Neovascularization
Bayer 28
Large-scale testing (Phase 3)Study completedNCT01396083
What this trial is testing

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Visual ImpairmentMacular EdemaCentral Retinal Vein Occlusion
Novartis Pharmaceuticals 243
Not applicableStudy completedNCT04543331
What this trial is testing

Observational Study to Evaluate Fluid Resolution and Effectiveness in Patients Receiving Beovu in Neovascular Age-related Macular Degeneration and Visual Impairment Due to Diabetic Macular Edema

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)Diabetic Macular Edema (DME)
Novartis Pharmaceuticals 572
Large-scale testing (Phase 3)Study completedNCT01171976
What this trial is testing

Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus

Who this might be right for
Diabetic Macular Edema
Novartis Pharmaceuticals 373
Not applicableActive Not RecruitingNCT07789691
What this trial is testing

Effects of Reformer Pilates and Vestibular Exercise Programs on Balance and Gait in Children With Visual Impairment

Who this might be right for
Visual Impairments
Marmara University 75
Not applicableStudy completedNCT02310880
What this trial is testing

Efficacy of Enhancing Low Vision Mobility Thru Visual Training in Virtual World

Who this might be right for
Low Vision
University of Alabama at Birmingham 35
Not applicableStudy completedNCT00555113
What this trial is testing

Evolution of Visual Impairment During Pseudoxanthoma Elasticum

Who this might be right for
Pseudoxanthoma Elasticum
European Georges Pompidou Hospital 38
Large-scale testing (Phase 3)Ended earlyNCT04603937
What this trial is testing

Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)

Who this might be right for
Diabetic Macular Edema
Kodiak Sciences Inc 459
Not applicableStudy completedNCT05904444
What this trial is testing

The Effect of Duration Between Sessions on Microperimetric Biofeedback Training in Patients With Maculopathies

Who this might be right for
Macular DegenerationLow VisionStargardt Disease
Aier Eye Hospital, Guangzhou 29
Large-scale testing (Phase 3)Study completedNCT02259088
What this trial is testing

A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) Patients

Who this might be right for
Diabetic Macular EdemaVisual Impairment
Novartis Pharmaceuticals 384
Not applicableStudy completedNCT01691027
What this trial is testing

Visuomotor Rehabilitation Training for Manual Task Deficits From Macular Scotomas

Who this might be right for
Scotoma, CentralCentral Visual Impairment
VA Office of Research and Development 4
Not applicableNot Yet RecruitingNCT06968702
What this trial is testing

Project ICOPE Brazil: Assessment of Intrinsic Capacity in Brazilian Older Adults

Who this might be right for
Intrinsic CapacityFrailtyAging+14 more
University of Sao Paulo 3,838
Not applicableUnknownNCT03285204
What this trial is testing

Relationship Between Neurological Disability and Visual Impairment in Patients With ALS or Friedreich's Ataxia

Who this might be right for
Amyotrophic Lateral Sclerosis
Jose Luis Urcelay Segura 90
Large-scale testing (Phase 3)Study completedNCT01976312
What this trial is testing

Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Central Retinal Vein Occlusion
Novartis Pharmaceuticals 252
Not applicableUnknownNCT04739137
What this trial is testing

Smart-TV Application for the Self Examination of the Distance Visual Acuity in Macular Edema Patients

Who this might be right for
Low VisionMacular EdemaRefractive Errors
Democritus University of Thrace 300
Not applicableStudy completedNCT06602102
What this trial is testing

Pilot Study on Improving Mobility and Universal Accessibility for Individuals With Visual Disabilities in Barcelona

Who this might be right for
Low Vision AidsLow VisionLow Vision Blindness+1 more
Universitat Politècnica de Catalunya 41
Not applicableStudy completedNCT02390245
What this trial is testing

Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study

Who this might be right for
GlaucomaGlaucoma SuspectDiabetic Retinopathy+10 more
Wills Eye 906
Not applicableEnded earlyNCT03423654
What this trial is testing

Spatial Cognitive Training

Who this might be right for
Blind
VA Office of Research and Development 6
Large-scale testing (Phase 3)Study completedNCT01922102
What this trial is testing

Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia

Who this might be right for
Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM)
Novartis Pharmaceuticals 457
Next Page